Lexaria Bioscience Corp. was incorporated on December 9, 2004 pursuant to the laws of the State of Nevada. The company is a biotechnology company that utilizes the patented DehydraTECHTM drug delivery technology to develop enhanced bioavailability of a wide range of fat-soluble active molecules and active pharmaceutical ingredients. DehydraTECH combines lipophilic molecules or APIs with specific long-chain fatty acids and carrier compounds, thereby improving the way they enter the bloodstream, increasing their effectiveness and allowing lower overall doses, while promoting healthier oral intake methods. The company's technology can be applied to a variety of therapeutic indications, including hypertension and heart disease, diabetes, etc. 

LEXX

LEXX Profile